<VariationArchive VariationID="2430183" VariationName="NM_006516.4(SLC2A1):c.1141del (p.Val381fs)" VariationType="Deletion" Accession="VCV002430183" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2023-02-25" MostRecentSubmission="2023-02-25">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2403686" VariationID="2430183">
      <GeneList>
        <Gene Symbol="SLC2A1" FullName="solute carrier family 2 member 1" GeneID="6513" HGNC_ID="HGNC:11005" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p34.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42925353" stop="42958868" display_start="42925353" display_stop="42958868" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="43391045" stop="43424846" display_start="43391045" display_stop="43424846" Strand="-" />
          </Location>
          <OMIM>138140</OMIM>
          <Haploinsufficiency last_evaluated="2016-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC2A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2016-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC2A1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006516.4(SLC2A1):c.1141del (p.Val381fs)</Name>
      <CanonicalSPDI>NC_000001.11:42927741:C:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p34.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42927742" stop="42927742" display_start="42927742" display_stop="42927742" variantLength="1" positionVCF="42927741" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="43393413" stop="43393413" display_start="43393413" display_stop="43393413" variantLength="1" positionVCF="43393412" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>V381fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.43393413del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.43393413del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.42927742del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.42927742del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008232.1" sequenceAccession="NG_008232" sequenceVersion="1" change="g.36435del">
            <Expression>NG_008232.1:g.36435del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006516.4" sequenceAccession="NM_006516" sequenceVersion="4" change="c.1141del" MANESelect="true">
            <Expression>NM_006516.4:c.1141del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006507.2" sequenceAccession="NP_006507" sequenceVersion="2" change="p.Val381fs">
            <Expression>NP_006507.2:p.Val381fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1132" sequenceAccession="LRG_1132">
            <Expression>LRG_1132:g.36435del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1132t1" sequenceAccession="LRG_1132t1">
            <Expression>LRG_1132t1:c.1141del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1132p1" sequenceAccession="LRG_1132p1" change="p.Val381Trpfs">
            <Expression>LRG_1132p1:p.Val381Trpfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006516.4(SLC2A1):c.1141del (p.Val381fs) AND Dystonia 9" Accession="RCV003128185" Version="3">
        <ClassifiedConditionList TraitSetID="8927">
          <ClassifiedCondition DB="MedGen" ID="C1832855">Dystonia 9</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-02-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-02-17" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-25" MostRecentSubmission="2023-02-25">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="8927" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1437" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dystonia 9</ElementValue>
                <XRef ID="MONDO:0010983" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CHOREOATHETOSIS, KINESIGENIC, WITH EPISODIC ATAXIA AND SPASTICITY</ElementValue>
                <XRef Type="MIM" ID="601042" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DYT9</ElementValue>
                <XRef Type="MIM" ID="601042" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CSE CHOREOATHETOSIS, PAROXYSMAL, WITH EPISODIC ATAXIA</ElementValue>
                <XRef Type="MIM" ID="601042" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS) is now known to be a continuum that includes the classic phenotype as well as paroxysmal exercise-induced dyskinesia and epilepsy (previously known as dystonia 18 [DYT18]) and paroxysmal choreoathetosis with spasticity (previously known as dystonia 9 [DYT9]), atypical childhood absence epilepsy, myoclonic astatic epilepsy, and paroxysmal non-epileptic findings including intermittent ataxia, choreoathetosis, dystonia, and alternating hemiplegia. The classic phenotype is characterized by infantile-onset seizures, delayed neurologic development, acquired microcephaly, and complex movement disorders. Seizures in classic early-onset Glut1 DS begin before age six months. Several seizure types occur: generalized tonic or clonic, focal, myoclonic, atypical absence, atonic, and unclassified. In some infants, apneic episodes and abnormal episodic eye-head movements similar to opsoclonus may precede the onset of seizures. The frequency, severity, and type of seizures vary among affected individuals and are not related to disease severity. Cognitive impairment, ranging from learning disabilities to severe intellectual disability, is typical. The complex movement disorder, characterized by ataxia, dystonia, and chorea, may occur in any combination and may be continuous, paroxysmal, or continual with fluctuations in severity influenced by environmental factors such as fasting or with infectious stress. Symptoms often improve substantially when a ketogenic diet is started.</Attribute>
                <XRef ID="NBK1430" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16656" />
                <XRef ID="16656" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301603</ID>
                <ID Source="BookShelf">NBK1430</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2011">
                <ID Source="PubMed">20482602</ID>
              </Citation>
              <XRef ID="53583" DB="Orphanet" />
              <XRef ID="C1832855" DB="MedGen" />
              <XRef ID="MONDO:0010983" DB="MONDO" />
              <XRef Type="MIM" ID="601042" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7109390" SubmissionDate="2023-02-22" DateLastUpdated="2023-02-25" DateCreated="2023-02-25">
        <ClinVarSubmissionID localKey="SUB12875777" submittedAssembly="GRCh38" title="SUB12875777" />
        <ClinVarAccession Accession="SCV003804170" DateUpdated="2023-02-25" DateCreated="2023-02-25" Type="SCV" Version="1" SubmitterName="Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan" OrgID="507274" OrganizationCategory="laboratory" OrgAbbreviation="GenomicaHPG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Patogenic Ib (PVS1, PM2, PM6)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <GeographicOrigin>Argentina</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0007704" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0011972" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001263" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC2A1">
              <Name>solute carrier family 2 member 1</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_006516.4:exon 9</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006516.4:c.1141del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="601042" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12875777</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7109390" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001263" MappingRef="HP">
        <MedGen CUI="C0557874" Name="Global developmental delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7109390" TraitType="Disease" MappingType="XRef" MappingValue="601042" MappingRef="OMIM">
        <MedGen CUI="C1832855" Name="Dystonia 9" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7109390" TraitType="Finding" MappingType="XRef" MappingValue="HP:0007704" MappingRef="HP">
        <MedGen CUI="C1847515" Name="Paroxysmal involuntary eye movements" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7109390" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011972" MappingRef="HP">
        <MedGen CUI="C0598121" Name="Hypoglycorrhachia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

